Tag: stem cells
December 10, 2018
Genetics Outlook 2019: CRISPR Technology Advances
With 2018 coming to a close, here's a look at the biggest genetics trends of the year and what's in...
April 29, 2018
5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent
Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ. April 20, 2018
Cynata Therapeutics Completes Patent Application to Cover Cymerus Stem Cell Technology
Australian stem cell and regenerative medicine company, Cynata Therapeutics Limited (ASX:CYP) announced that it has completed the filing of a... April 19, 2018
Hemostemix Announces US FDA Clinical Trial Approval
Hemostemix (TSXV:HEM), a clinical-stage, autologous cell-therapy company, is pleased to announce that the United States Food and Drug Administration has raised...
April 12, 2018
ImmunoCellular Therapeutics Achieves Key Genetic Milestone in Research
This proof-of-concept trial proves what the company is able to do with its Stem-to-T-Cell program, but will it generate returns? April 10, 2018
Neuralstem Announces First Surgery Completed in Cervical Cohort of Phase 1 Clinical Trial in Patients with Chronic Spinal Cord Injury
Neuralstem (Nasdaq:CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell technology,...
April 1, 2018